2 results
Approved WMOCompleted
To assess the efficacy and safety of two Pasireotide LAR regimens in CD patients.
Approved WMOCompleted
PrimaryTo estimate the treatment effect of everolimus in combination with pasireotide LAR relative to everolimus alone on progression-free survival (PFS) in patients with advanced PNET and to assess the predictive probability of success in a…